These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21421114)

  • 21. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of cytogenetic and pathohistologic profiles in glioblastoma.
    Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C
    Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
    Debinski W; Gibo DM; Hulet SW; Connor JR; Gillespie GY
    Clin Cancer Res; 1999 May; 5(5):985-90. PubMed ID: 10353730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biology of glioma.
    Marumoto T; Saya H
    Adv Exp Med Biol; 2012; 746():2-11. PubMed ID: 22639155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms regulating glioma invasion.
    Paw I; Carpenter RC; Watabe K; Debinski W; Lo HW
    Cancer Lett; 2015 Jun; 362(1):1-7. PubMed ID: 25796440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
    Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
    Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy for malignant glioma.
    Lesniak MS
    Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for recurrent glioblastoma: pitfalls and future trends.
    Franceschi E; Tosoni A; Bartolini S; Mazzocchi V; Fioravanti A; Brandes AA
    Expert Rev Anticancer Ther; 2009 May; 9(5):613-9. PubMed ID: 19445578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for glioblastoma.
    Aghi M; Chiocca EA
    Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Directions in the Treatment of Glioblastoma.
    Reitman ZJ; Winkler F; Elia AEH
    Semin Neurol; 2018 Feb; 38(1):50-61. PubMed ID: 29548052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies.
    Costa PM; Cardoso AL; Mano M; de Lima MC
    CNS Neurol Disord Drug Targets; 2015; 14(2):222-38. PubMed ID: 25613511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in therapy for glioblastoma.
    Clarke J; Butowski N; Chang S
    Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.
    Mohyeldin A; Chiocca EA
    Cancer J; 2012; 18(1):82-8. PubMed ID: 22290261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival comparison between glioblastoma multiforme and other incurable cancers.
    Tran B; Rosenthal MA
    J Clin Neurosci; 2010 Apr; 17(4):417-21. PubMed ID: 20167494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant astrocytic glioma: genetics, biology, and paths to treatment.
    Furnari FB; Fenton T; Bachoo RM; Mukasa A; Stommel JM; Stegh A; Hahn WC; Ligon KL; Louis DN; Brennan C; Chin L; DePinho RA; Cavenee WK
    Genes Dev; 2007 Nov; 21(21):2683-710. PubMed ID: 17974913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
    Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
    Mrugala MM
    Discov Med; 2013 Apr; 15(83):221-30. PubMed ID: 23636139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
    Kim HJ; Kim DY
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.